LINC01133 and breast carcinoma: GSEA analysis revealed a notable trend of proliferation traits focused on the subset of ER+ breast cancer exhibiting low levels of LINC01133 (Figure 2a) suggesting that LINC01133 might mediate the proliferation of ER+ breast cancer.